Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant’s trade marks should be cancelled because they’re too generic and are being used to sell products that don’t exclusively contain the a2 protein.
Pauline Hanson appeals $250,000 defamation judgment
OTC derivatives trader can’t pause ASIC’s 8-year ban
Judge blames law firm for delays in Romeo’s class actions
‘Everyone will believe him and not you’: Qantas sued for sex discrimination by female pilot
Finish detergent maker says trade mark judgment doesn’t wash
Surgeon sues Nine, Fairfax for defamation
Biogen, Pharmacor lay down swords in battle over MS drug patent
Save (1) Please login to bookmark Close Username or Email Address Password Remember Me Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS drug Tecfidera. In an October 14 order by Federal Court Justice Helen Rofe, Biogen’s infringement claims…